Squarepoint Ops LLC Eagle Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.34 - $5.6 $59,535 - $99,820	17,825 New	17,825 $99,000
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $134,084 - $440,481	28,960 New	28,960 $151,000
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $33,129 - $45,066	-1,322 Reduced 3.8%	33,498 $950,000
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $272,531 - $433,890	10,910 Added 45.63%	34,820 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $412,997 - $736,579	15,632 Added 188.84%	23,910 $632,000
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $49,181 - $61,209	-1,192 Reduced 12.59%	8,278 $368,000
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $47,611 - $56,176	1,068 Added 12.71%	9,470 $469,000
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $384,979 - $478,073	8,402 New	8,402 $428,000
Q3 2021 Nov 15, 2021	SELL	$43.79 - $55.78 $227,576 - $289,888	-5,197 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$36.86 - $44.5 $191,561 - $231,266	5,197 New	5,197 $222,000
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $337,921 - $427,179	-8,381 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $206,639 - $254,287	-4,953 Reduced 37.15%	8,381 $390,000
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $299,010 - $414,188	8,077 Added 153.64%	13,334 $566,000
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $490,255 - $623,816	-11,338 Reduced 68.32%	5,257 $252,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $548,682 - $958,957	-15,964 Reduced 49.03%	16,595 $763,000
Q4 2019 Feb 14, 2020	BUY	$54.32 - $64.31 $1.34 Million - $1.59 Million	24,721 Added 315.4%	32,559 $1.96 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $999,555 - $1.13 Million	-18,771 Reduced 70.54%	7,838 $443,000
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $353,816 - $443,693	-7,591 Reduced 22.2%	26,609 $1.48 Million
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $154,176 - $206,658	-3,988 Reduced 10.44%	34,200 $1.73 Million
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $1.4 Million - $2.59 Million	38,188 New	38,188 $1.54 Million
Q2 2018 Aug 14, 2018	SELL	$51.25 - $76.62 $243,283 - $363,715	-4,747 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $2.48 Million - $3.18 Million	-47,613 Reduced 90.93%	4,747 $250,000
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $2.6 Million - $3.19 Million	52,360	52,360 $2.8 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account